When still at the early stage, certain toxicology studies can be exempted from GLP regulations. The main advantage of running non-GLP toxicology studies is to mitigate the risk of failure at the preclinical level, before deciding whether to push a study forward or to terminate it. Designing a study that meets the needs of your program and accurately analyzes the potential toxicologic risks of your compound requires deep knowledge and expertise in pharmacology and toxicology.

A knowledge we proudly have at PharmaLegacy. You can keep scrolling to check out our non-GLP toxicology models, and if you can’t find what you’re looking for, rest assured – we make custom made models!